Scienture Holdings, Inc.

FRC's fair value estimate for Scienture Holdings, Inc., and the rating behind it. SCNX last traded at $2.93; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Scienture Holdings, Inc.. Starting points for Scienture Holdings, Inc.: EPS -$23.95, beta 4.08 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Scienture Holdings, Inc.. Scienture Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Scienture Holdings, Inc.. Trailing twelve-month EPS for Scienture Holdings, Inc. stands at -$23.95. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Scienture Holdings, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Scienture Holdings, Inc. valued side by side against its closest peers. Scienture Holdings, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Scienture Holdings, Inc., and how their positions are changing. At a $4.8M market value, institutional positions materially move Scienture Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Scienture Holdings, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Scienture Holdings, Inc.. Scienture Holdings, Inc. is a $4.8M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Scienture Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Scienture Holdings, Inc.. Coverage tracks Scienture Holdings, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.